U.S. Senate · 117th Congress · S. 4378
Hatch-Waxman Improvement Act of 2022
A bill to reauthorize a provision of the Federal Food, Drug, and Cosmetic Act pertaining to drugs containing single enantiomers.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Roger MarshallR-KS
- Introduced
- June 13, 2022, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (0)
No member has cosponsored this bill.